PreprintAll rights reservedmedRxiv
Heteroresistance to first-line beta-lactams among Gram-negative bloodstream isolates reported susceptible by standard-of-care testing: a prospective two-centre study across a high- and a low-resistance setting
- 1Gemelli University Hospital Foundation IRCCS
Related
- Bloodstream Infections in Patients with Malignancy: Microbiological Epidemiology, Antimicrobial Resistance, and Factors Associated with Mortality in a Nine-Year Single-Center Retrospective Cohort
- Pooled prevalence of third-generation cephalosporin resistance among Escherichia coli bloodstream isolates in Southeast Asia: protocol for systematic review and meta-analysis.
- Early best available antibiotic therapy for multidrug-resistant gram-negative bloodstream infections: a target trial emulation
- Routine Serial Follow-up Blood Cultures After a Negative Result Within 48 Hours of Methicillin-susceptible Staphylococcus aureus Bacteremia: Low Yield, High Cost
- Real-life evaluation of BioFire® BCID2 and Vitek® REVEALTM for Gram-negative bloodstream infections in critical care
BibTeX
@misc{squitieri2026heteroresistance,
title = {{Heteroresistance to first-line beta-lactams among Gram-negative bloodstream isolates reported susceptible by standard-of-care testing: a prospective two-centre study across a high- and a low-resistance setting}},
author = {D. Squitieri and G. Menchinelli and B. Berinson and N. Degel-Brossmann and B. Posteraro and H. Rohde and M. Sanguinetti},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.07.26362422},
url = {https://www.medrxiv.org/content/10.64898/2026.09.07.26362422v1},
}
RIS
TY - UNPB
TI - Heteroresistance to first-line beta-lactams among Gram-negative bloodstream isolates reported susceptible by standard-of-care testing: a prospective two-centre study across a high- and a low-resistance setting
AU - D. Squitieri
AU - G. Menchinelli
AU - B. Berinson
AU - N. Degel-Brossmann
AU - B. Posteraro
AU - H. Rohde
AU - M. Sanguinetti
PY - 2026
DA - 2026/09/07
PB - medRxiv
DO - 10.64898/2026.09.07.26362422
UR - https://www.medrxiv.org/content/10.64898/2026.09.07.26362422v1
ER -